138 related articles for article (PubMed ID: 23254778)
1. Characterization of WWOX inactivation in murine mammary gland development.
Abdeen SK; Salah Z; Khawaled S; Aqeilan RI
J Cell Physiol; 2013 Jul; 228(7):1391-6. PubMed ID: 23254778
[TBL] [Abstract][Full Text] [Related]
2. Conditional inactivation of the mouse Wwox tumor suppressor gene recapitulates the null phenotype.
Abdeen SK; Del Mare S; Hussain S; Abu-Remaileh M; Salah Z; Hagan J; Rawahneh M; Pu XA; Russell S; Stein JL; Stein GS; Lian JB; Aqeilan RI
J Cell Physiol; 2013 Jul; 228(7):1377-82. PubMed ID: 23254685
[TBL] [Abstract][Full Text] [Related]
3. WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3.
Gourley C; Paige AJ; Taylor KJ; Ward C; Kuske B; Zhang J; Sun M; Janczar S; Harrison DJ; Muir M; Smyth JF; Gabra H
Cancer Res; 2009 Jun; 69(11):4835-42. PubMed ID: 19458077
[TBL] [Abstract][Full Text] [Related]
4. Conditional Wwox deletion in mouse mammary gland by means of two Cre recombinase approaches.
Ferguson BW; Gao X; Kil H; Lee J; Benavides F; Abba MC; Aldaz CM
PLoS One; 2012; 7(5):e36618. PubMed ID: 22574198
[TBL] [Abstract][Full Text] [Related]
5. Wwox inactivation enhances mammary tumorigenesis.
Abdeen SK; Salah Z; Maly B; Smith Y; Tufail R; Abu-Odeh M; Zanesi N; Croce CM; Nawaz Z; Aqeilan RI
Oncogene; 2011 Sep; 30(36):3900-6. PubMed ID: 21499303
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
Zinser GM; Welsh J
Carcinogenesis; 2004 Dec; 25(12):2361-72. PubMed ID: 15333467
[TBL] [Abstract][Full Text] [Related]
7. WWOX: its genomics, partners, and functions.
Del Mare S; Salah Z; Aqeilan RI
J Cell Biochem; 2009 Nov; 108(4):737-45. PubMed ID: 19708029
[TBL] [Abstract][Full Text] [Related]
8. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
Toyo-oka K; Bowen TJ; Hirotsune S; Li Z; Jain S; Ota S; Escoubet-Lozach L; Garcia-Bassets I; Lozach J; Rosenfeld MG; Glass CK; Eisenman R; Ren B; Hurlin P; Wynshaw-Boris A
Cancer Res; 2006 Jun; 66(11):5565-73. PubMed ID: 16740691
[TBL] [Abstract][Full Text] [Related]
9. WW domain-containing oxidoreductase's role in myriad cancers: clinical significance and future implications.
Gardenswartz A; Aqeilan RI
Exp Biol Med (Maywood); 2014 Mar; 239(3):253-63. PubMed ID: 24510053
[TBL] [Abstract][Full Text] [Related]
10. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
[TBL] [Abstract][Full Text] [Related]
11. WWOX in biological control and tumorigenesis.
Aqeilan RI; Croce CM
J Cell Physiol; 2007 Aug; 212(2):307-10. PubMed ID: 17458891
[TBL] [Abstract][Full Text] [Related]
12. Somatic loss of WWOX is associated with TP53 perturbation in basal-like breast cancer.
Abdeen SK; Ben-David U; Shweiki A; Maly B; Aqeilan RI
Cell Death Dis; 2018 Aug; 9(8):832. PubMed ID: 30082886
[TBL] [Abstract][Full Text] [Related]
13. Deletion of Tip30 leads to rapid immortalization of murine mammary epithelial cells and ductal hyperplasia in the mammary gland.
Pecha J; Ankrapp D; Jiang C; Tang W; Hoshino I; Bruck K; Wagner KU; Xiao H
Oncogene; 2007 Nov; 26(53):7423-31. PubMed ID: 17533366
[TBL] [Abstract][Full Text] [Related]
14. Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth.
Andrechek ER; White D; Muller WJ
Oncogene; 2005 Jan; 24(5):932-7. PubMed ID: 15580295
[TBL] [Abstract][Full Text] [Related]
15. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
[TBL] [Abstract][Full Text] [Related]
16. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH
Cancer Res; 1996 Apr; 56(8):1775-85. PubMed ID: 8620493
[TBL] [Abstract][Full Text] [Related]
17. Reversing effect of exogenous WWOX gene expression on malignant phenotype of primary cultured lung carcinoma cells.
Zhou YL; Li YC; Shou F; Liu CQ; Pu Y; Tang H
Chin Med J (Engl); 2010 Mar; 123(5):615-20. PubMed ID: 20367991
[TBL] [Abstract][Full Text] [Related]
18. Roles of the WWOX in pathogenesis and endocrine therapy of breast cancer.
Li J; Liu J; Ren Y; Liu P
Exp Biol Med (Maywood); 2015 Mar; 240(3):324-8. PubMed ID: 25476151
[TBL] [Abstract][Full Text] [Related]
19. WWOX: a fragile tumor suppressor.
Schrock MS; Huebner K
Exp Biol Med (Maywood); 2015 Mar; 240(3):296-304. PubMed ID: 25538133
[TBL] [Abstract][Full Text] [Related]
20. An opposing view on WWOX protein function as a tumor suppressor.
Watanabe A; Hippo Y; Taniguchi H; Iwanari H; Yashiro M; Hirakawa K; Kodama T; Aburatani H
Cancer Res; 2003 Dec; 63(24):8629-33. PubMed ID: 14695174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
